Regulatory, Safety, Devices, Market Access, and Public-Facing Work

Lay summary of clinical-trial results

Chapter 26 of 291 min read

Explain the study purpose, who participated, how it was done, main findings, safety or adverse reactions, limitations, and where more information is available. Clarify that group results do not determine an individual's treatment. Use balanced visuals and absolute numbers.

Phase I and early-development studies may require extra explanation because endpoints, healthy-volunteer context, and future product use may be unfamiliar or uncertain. State what was and was not learned.